These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21127338)

  • 1. Landmark advances in the development of erythropoietin.
    Fisher JW
    Exp Biol Med (Maywood); 2010 Dec; 235(12):1398-411. PubMed ID: 21127338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tainted glory--doping and athletic performance.
    Noakes TD
    N Engl J Med; 2004 Aug; 351(9):847-9. PubMed ID: 15329417
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin, the first century.
    Ribatti D
    Leuk Res; 2008 Aug; 32(8):1169-72. PubMed ID: 18339424
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin after a century of research: younger than ever.
    Jelkmann W
    Eur J Haematol; 2007 Mar; 78(3):183-205. PubMed ID: 17253966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of erythropoietin and related strategies to stimulate erythropoiesis.
    Eckardt KU
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1081-5. PubMed ID: 11892917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pleiotropic effects of erythropoietin].
    Kes P; Basić-Jukić N; Furić-Cunko V
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of erythropoietin: anemia and beyond.
    Guglin ME; Koul D
    Cardiol Rev; 2006; 14(4):200-4. PubMed ID: 16788333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the field of hematology in the last 100 years: Erythropoietin].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):1983-8. PubMed ID: 12187661
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis.
    Adamson JW
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1501-6. PubMed ID: 2849202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin--physiology and therapeutic potentialities].
    Möllmann M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology.
    Goodnough LT
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin: indications and measurement].
    Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
    Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin in sports: a new look at an old problem.
    Scott J; Phillips GC
    Curr Sports Med Rep; 2005 Aug; 4(4):224-6. PubMed ID: 16004833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin: current status.
    Bunn HF
    Yale J Biol Med; 1990; 63(5):381-6. PubMed ID: 2293499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin.
    Bunn HF
    Cold Spring Harb Perspect Med; 2013 Mar; 3(3):a011619. PubMed ID: 23457296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of erythropoietin in chronic heart failure: from the correction of anemia to improved perfusion and reduced apoptosis?
    Timmer SA; De Boer K; Knaapen P; Götte MJ; Van Rossum AC
    J Card Fail; 2009 May; 15(4):353-61. PubMed ID: 19398085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.
    Bogoyevitch MA
    Cardiovasc Res; 2004 Aug; 63(2):208-16. PubMed ID: 15249178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
    Jelkmann W
    Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.